QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:OM

Outset Medical (OM) Stock Forecast, Price & News

$23.54
-0.34 (-1.42%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$22.61
$24.07
50-Day Range
$20.22
$48.16
52-Week Range
$19.47
$60.33
Volume
521,247 shs
Average Volume
453,248 shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.04
30 days | 90 days | 365 days | Advanced Chart
Receive OM News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Outset Medical logo

About Outset Medical

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
444
Year Founded
N/A

Sales & Book Value

Annual Sales
$102.60 million
Book Value
$7.23 per share

Profitability

Net Income
$-131.93 million
Net Margins
-125.91%
Pretax Margin
-125.66%

Debt

Price-To-Earnings

Miscellaneous

Free Float
45,882,000
Market Cap
$1.13 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/03/2021
Today
5/19/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.60 out of 5 stars

Medical Sector

975th out of 1,418 stocks

Electromedical Equipment Industry

17th out of 29 stocks

Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -













Outset Medical (NASDAQ:OM) Frequently Asked Questions

Is Outset Medical a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Outset Medical stock.
View analyst ratings for Outset Medical
or view top-rated stocks.

When is Outset Medical's next earnings date?

Outset Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Outset Medical
.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.65) EPS for the quarter, topping analysts' consensus estimates of ($0.84) by $0.19. The business had revenue of $26.32 million for the quarter, compared to analyst estimates of $25.13 million. Outset Medical had a negative trailing twelve-month return on equity of 35.58% and a negative net margin of 125.91%. During the same period last year, the business earned ($3.44) earnings per share.
View Outset Medical's earnings history
.

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $144.00 million-$150.00 million, compared to the consensus revenue estimate of $146.21 million.

What price target have analysts set for OM?

3 brokerages have issued 12-month target prices for Outset Medical's stock. Their forecasts range from $50.00 to $60.00. On average, they anticipate Outset Medical's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 133.6% from the stock's current price.
View analysts' price targets for Outset Medical
or view top-rated stocks among Wall Street analysts.

Who are Outset Medical's key executives?
Outset Medical's management team includes the following people:
  • Ms. Leslie L. Trigg, CEO & Chairman (Age 51, Pay $1.54M) (LinkedIn Profile)
  • Mr. Nabeel Ahmed, CFO, Principal Financial Officer & Principal Accounting Officer (Age 46, Pay $647.57k) (LinkedIn Profile)
  • Mr. Martin Vazquez, Chief Operating Officer (Age 51, Pay $695.99k) (LinkedIn Profile)
  • Mr. Jean-Olivier Racine, Chief Technology Officer (Age 40, Pay $540.93k)
  • Mr. John L. Brottem, Gen. Counsel & Sec. (Age 48, Pay $654.98k) (LinkedIn Profile)
  • Mr. James S. Mazzola, Head of Investor Relations
  • Nicole Shannon, Director of Marketing Communications
  • Ms. Stacey L. Porter, Chief People Officer (Age 47)
  • Dr. Michael Aragon M.D., Chief Medical Officer
  • Ms. Tonya Saffer, Head of Gov. Affairs & Market Access
When did Outset Medical IPO?

(OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

What is Outset Medical's stock symbol?

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.05%), BlackRock Inc. (8.61%), JPMorgan Chase & Co. (6.38%), Champlain Investment Partners LLC (4.28%), Bellevue Group AG (4.22%) and Jennison Associates LLC (3.01%). Company insiders that own Outset Medical stock include D Keith Grossman, James F Hinrichs, John L Brottem, John L Brottem, Leslie Trigg, Martin Vazquez, Nabeel Ahmed, Pincus X LP Warburg, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc.
View institutional ownership trends for Outset Medical
.

Which major investors are selling Outset Medical stock?

OM stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Wasatch Advisors Inc., TimesSquare Capital Management LLC, Renaissance Technologies LLC, Assenagon Asset Management S.A., Northern Trust Corp, Citigroup Inc., and PDT Partners LLC. Company insiders that have sold Outset Medical company stock in the last year include D Keith Grossman, John L Brottem, Leslie Trigg, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter, and Steven S Williamson.
View insider buying and selling activity for Outset Medical
or view top insider-selling stocks.

Which major investors are buying Outset Medical stock?

OM stock was bought by a variety of institutional investors in the last quarter, including Bellevue Group AG, Bank of New York Mellon Corp, Vanguard Group Inc., Champlain Investment Partners LLC, Goldman Sachs Group Inc., Sectoral Asset Management Inc., JPMorgan Chase & Co., and Woodline Partners LP. Company insiders that have bought Outset Medical stock in the last two years include James F Hinrichs, and Nabeel Ahmed.
View insider buying and selling activity for Outset Medical
or or view top insider-buying stocks.

How do I buy shares of Outset Medical?

Shares of OM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Outset Medical's stock price today?

One share of OM stock can currently be purchased for approximately $23.54.

How much money does Outset Medical make?

Outset Medical has a market capitalization of $1.13 billion and generates $102.60 million in revenue each year. The company earns $-131.93 million in net income (profit) each year or ($2.960010) on an earnings per share basis.

How many employees does Outset Medical have?

Outset Medical employs 444 workers across the globe.

What is Outset Medical's official website?

The official website for Outset Medical is outsetmedical.com.

How can I contact Outset Medical?

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company can be reached via phone at 669-231-8200 or via email at [email protected].

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.